Which Healthcare Startups Won the MedCity INVEST Pitch Perfect Contest?

The annual MedCity INVEST conference this week offered a platform for healthcare startups investors to come together, network, and exchange ideas. The Pitch Perfect contest was the centerpiece of the event, highlighting how different companies are imagining healthcare innovation. The competition saw 23 healthcare startups across biopharma, medical devices, and health tech geared for consumers/employers … Read more

Payers Need Clear Outcomes Data to Reimburse Digital Health, Experts Argue

From Left to Right: Yuri Goryunov, William Brady, Alyssa Jaffee and Stephen Smith The pandemic prompted a great need for technology-enabled care delivery, so the regulations surrounding reimbursement for these services were tossed out the window in 2020. Now that the public health emergency has ended, the healthcare industry has to figure out how it … Read more

Canadian Showcase at MedCity INVEST Champions Healthcare Innovation

At MedCity INVEST, held this week at the Ritz Carlton in Chicago, Canadian healthcare startups presented their technologies and explained how they plan to address pain points in healthcare across health tech, medtech and biopharma. Presented by the Consulate General of Canada in Chicago, which is currently celebrating the 75th anniversary of its diplomatic presence in … Read more

How State Medicaid Programs Are Responding to the Behavioral Health Crisis

New research shows that 33 states do not provide Medicaid coverage for all three core crisis services that should be available to those in need of behavioral health support: crisis hotlines, mobile crisis units and crisis stabilization. The Substance Abuse and Mental Health Services Administration (SAMHSA) identified these as necessary services for those in a … Read more

How Hospitals Are Reducing Gun Violence, Protecting Patients and Staff

From left to right: Parthi Desai, Angelique Richard, Andra Medea, Elizabeth Sheesley Martin, and Jose Prince Clinicians are on the front lines in caring for gunshot victims. The continuous flow of these victims to emergency departments has sparked the medical community to speak out on ways to reduce the violence. Dr. Jose Prince, vice president … Read more

Why Medicare Should Treat Obesity as a Disease

Obesity rates among older Americans are sharply rising. By 2030, nearly half of Medicare beneficiaries will have obesity, up from 28% in 2010. Even more concerning, the number of people over the age of 65 with severe obesity (BMI over 40) is expected to double in the twenty-year period from 2010 to 2030. The increasing … Read more

MedCity Pivot Podcast: It’s Time To Talk About Responsible AI

Suchi Saria, CEO of Bayesian Health and Associate Professor of Medicine, Johns Hopkins University It’s hard to get away from the topic of large language models, chatGPT and more broadly, artificial intelligence in healthcare. It’s all over the news, on social media, in the conferences we go to (including MedCity’s own INVEST conference that concluded … Read more

AI/ML: Considerations of Healthcare’s New Frontier

Artificial Intelligence (AI) and Machine Learning (ML) is bringing healthcare into a new frontier with vast potential to improve clinical outcomes, manage resources, and support therapeutic development. They also raise ethical, legal, and operational conundrums that can, in turn, amplify risk. Where does AI and ML stand today? Go, stop, go. 2023 has brought a … Read more

Most Medicaid Enrollees Are Unaware About the Return to Eligibility Renewals

About 65% of Medicaid enrollees are unsure if states are allowed to now disenroll people from Medicaid if they aren’t eligible anymore or didn’t renew coverage, and 7% incorrectly believe  that states can’t do this, a new analysis showed. During the Covid-19 pandemic and under the continuous enrollment provision, states were barred from disenrolling people … Read more

FDA Nod Makes Pfizer’s Paxlovid the First Approved Oral Covid-19 Antiviral Drug

Pfizer’s Paxlovid now has full FDA approval for treating mild-to-moderate Covid-19, a regulatory decision that makes the pill the first oral antiviral for the novel coronavirus. The approval announced Thursday covers the treatment of adults who are at high risk of progressing to severe Covid-19 that could lead to hospitalization or death. Paxlovid’s emergency authorization … Read more